Drug Action
Deflazacort is derived from prednisolone; it has predominantly glucocorticoid activity.
PDF page 733
Loading InternPractice…
Drug reference
Deflazacort is derived from prednisolone; it has predominantly glucocorticoid activity.
PDF page 733
Suppression of inflammatory and allergic disorders ▶BY MOUTH ▶Adult: Maintenance 3–18 mg daily Suppression of inflammatory and allergic disorders (acute disorders) ▶BY MOUTH continued → ▶Adult: Initially up to 120 mg daily Inflammatory and allergic disorders ▶BY MOUTH ▶Child 1 month–11 years: 0.25–1.5 mg/kg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations ▶Child 12–17 years: 3–18 mg once daily or on alternate days; increased if necessary up to 2.4 mg/kg daily (max. per dose 120 mg), in emergency situations
PDF pages 733, 734
→Appendix 1: corticosteroids Endocrine system
PDF page 734
▶Uncommon Oedema
PDF page 734
Dose adjustments Manufacturer advises adjust to the minimum effective dose.
PDF page 734
There can be variation in the licensing of different medicines containing the same drug. Forms available from special-order manufacturers include: tablet Tablet CAUTIONARY AND ADVISORY LABELS 5, 10 ▶Calcort (Sanofi) Deflazacort 6 mg Calcort 6mg tablets | 60 tablet P £15.82 DT = £15.82 eiiii F 709
PDF page 734
Patient counselling is advised for deflazacort tablets (steroid card).
PDF page 734
0.25–1.5 mg/kg once daily or on
First-line fragment. Read the complete Indications and Dose section above.
PDF page 734
3–18 mg once daily or on alternate
First-line fragment. Read the complete Indications and Dose section above.
PDF page 734